(Q80166499)

English

Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial

scientific article published on 24 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

follicular lymphoma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Paolo Corradini

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Vallet S

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Benedetti F

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Martelli M

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Callea V

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Patti C

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Coser P

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Perrotti A

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sorio M

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Boccomini C

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Pulsoni A

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Stelitano C

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Scimè R

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Boccadoro M

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

De Marco F

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Zanni M

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tarella C

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

24 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1840-1847

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932351%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404346

0 references

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical course of follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Future directions in radioimmunotherapy for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

131I-tositumomab therapy as initial treatment for follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment strategies in follicular lymphomas: current status and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for lymphoma CR1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404346

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80166499&oldid=2005238063"